Furthermore, treatment of melanoma cells with a specific inhibitor of the MAPK pathway or overexpression of dominant negative mutants of MEK induce melanogenesis by increasing tyrosinase expression [33]. This evidence concerns the gene MAP2K7 and melanoma.